Market News

US News

20 stories
zacks

Are Options Traders Betting on a Big Move in Ames National Stock?

Investors in Ames National Corporation ATLO need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2026 $22.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows h…

Zacks en
StocksUS
zacks

Can Centene's Integrated Healthcare Model Support Earnings Growth?

Centene Corporation's CNC integrated healthcare model is supporting its earnings potential by combining government-sponsored health plans with coordinated clinical services, pharmacy benefits and community-based care. This approach helps the company to manage medical costs more effectively while im…

Zacks en
StocksUS
zacks

Can AT&T's Build-A-Plan Expansion Strengthen Its Competitive Edge?

AT&T Inc. T is aiming to extend its Build-A-Plan offering to give customers greater flexibility, personalization and value across wireless and home Internet services. The updated offering intends to deliver a more seamless and convenient experience for customers both at home and outside.The enhance…

Zacks en
StocksUS
zacks

Can ExxonMobil's Upstream Business Thrive With Oil Below $70?

Exxon Mobil Corporation XOM has a massive footprint in the Permian, the most prolific oil and gas play in the United States, and offshore Guyana. In the Permian, the integrated giant has been employing lightweight proppant technology and hence is capable of boosting its well recoveries by up to as…

Zacks en
StocksUS
zacks

Tango Therapeutics Rides a New Precision Oncology Trend in 2026

Tango Therapeutics TNGX is becoming a clearer test of how precision oncology can shape biotech value in 2026. Its story now centers on MTAP-deleted cancers, synthetic lethality and targeted combinations.For investors, the issue is not whether Tango fits the trend. It does. The question is whether v…

Zacks en
StocksUS
zacks

Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?

Tango Therapeutics TNGX has become one of 2026’s more dramatic biotechnology stories, with shares up 224.3% year to date and 404.1% over the past year.That rally reflects real clinical progress, but it also raises the bar. Tango remains a clinical-stage company with no approved products, no recurri…

Zacks en
StocksUS
gurufocus

Nvidia Expands AI Factory Revenue Model

Nvidia Corp. (NVDA, Financials) said it has partnered with AI cloud companies to deploy large-scale, multi-tenant AI factories through a revenue-sharing and credit-support model.Under the plan, cloud providers will sell services delivered through Nvidia DSX AI factories, which are designed to produ…

GuruFocus en
StocksUS